Full Name
LUK JOHN MOON CHING
(not current staff)
Variants
Luk, J.M.
LUK JOHN MOON CHING
 
Main Affiliation
 
 
Email
phcljmc@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Type:  Article

Results 1-8 of 8 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
110-Jul-2012A morpho-molecular prognostic model for hepatocellular carcinomaSrivastava, S ; Wong, KF ; Ong, CW ; Chan, YH ; Yeoh, KG ; Teh, M ; Luk, JM ; Salto-Tellez, M 
217-May-2017Biotransformation of volatiles in fermented osmanthus (Osmanthus fragrans) flowers by yeastYC Xiong; J Luk ; MW Cheong; Philip Curran; S.-Q. Liu ; KH Ng; B Yu
32011Interleukin 17a promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expressionLi J.; Lau G.K.-K.; Chen L. ; Dong S.-s.; Lan H.-Y.; Huang X.-R.; Li Y.; Luk J.M. ; Yuan Y.-F.; Guan X.-y.
42012Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 ExpressionLi J.; Lau G.; Chen L. ; Yuan Y.-F.; Huang J.; Luk J.M. ; Xie D.; Guan X.-Y.
55-Apr-2010Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)Sun, S.; Poon, R.T.P.; Lee, N.P.; Yeung, C.; Chan, K.L.; Ng, I.O.L.; Day, P.J.R.; Luk, J.M. 
62009Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implicationsChan, K.L.; Wong, K.F.; Luk, J.M. 
7Jan-2011Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinomaChung, Y.; Law, S.; Kwong, D.L.W.; Luk, J.M. 
8Mar-2012Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agentsWong, K.-F. ; Yuan, Y.; Luk, J.M.